Invention Grant
- Patent Title: Crystalline forms of plasma kallikrein inhibitors
-
Application No.: US16922064Application Date: 2020-07-07
-
Publication No.: US11306061B2Publication Date: 2022-04-19
- Inventor: Sukanto Sinha , Tamie Chilcote , Julian Scott Northen , Jamie Marshall
- Applicant: Rezolute, Inc. , ActiveSite Pharmaceuticals, Inc.
- Applicant Address: US CA Redwood City; US CA San Francisco
- Assignee: Rezolute, Inc.,ActiveSite Pharmaceuticals, Inc.
- Current Assignee: Rezolute, Inc.,ActiveSite Pharmaceuticals, Inc.
- Current Assignee Address: US CA Redwood City; US CA San Francisco
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Main IPC: C07D231/14
- IPC: C07D231/14
Abstract:
Pure crystalline forms of 1-benzyl-N-(4-carbamimidoylbenzyl)-1H-pyrazole-4-carboxamide acetate, and an amorphous form, pharmaceutical compositions thereof, and methods for making the same, are disclosed.
Public/Granted literature
- US20210009525A1 CRYSTALLINE FORMS OF PLASMA KALLIKREIN INHIBITORS Public/Granted day:2021-01-14
Information query
